Biocure Technology, Inc. 致力于生物类似药产品的研发和商业化。公司总部位于不列颠哥伦比亚省温哥华。该公司于2008年3月27日上市。公司专注于自主研发和推广CAR-T细胞疗法,用于治疗慢性淋巴细胞白血病和实体瘤癌症。此外,公司还在开发用于癌症治疗的生物类似药技术。公司的产品包括干扰素β、雷珠单抗和聚乙二醇化非格司亭。
BICTF stock price ended at $0.01 on 星期三, after rising Infinity%
On the latest trading day May 14, 2025, the stock price of BICTF rose by Infinity%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 38.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 39.0K shares were traded, equating to a market value of approximately --.